Maternal serum placental growth factor at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia

Competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 35-37 weeks' gestation

(2016) S. Andrietti et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history

(2015) A. Tsiakkas et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Competing Risks Model in Screening for Preeclampsia by Serum Placental Growth Factor and Soluble fms-Like Tyrosine Kinase-1 at 30-33 Weeks' Gestation

(2014) Jonathan Lai et al.   FETAL DIAGNOSIS AND THERAPY

Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis

(2013) S. Roberge et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

A Competing Risks Model in Early Screening for Preeclampsia

(2012) David Wright et al.   FETAL DIAGNOSIS AND THERAPY

Turning the Pyramid of Prenatal Care

(2011) Kypros H. Nicolaides   FETAL DIAGNOSIS AND THERAPY

Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks

(2011) Ranjit Akolekar et al.   PRENATAL DIAGNOSIS

Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy

(2010) Emmanuel Bujold et al.   OBSTETRICS AND GYNECOLOGY

Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial

(2009) Corine M Koopmans et al.   LANCET

The Global Impact of Pre-eclampsia and Eclampsia

(2009) Lelia Duley   SEMINARS IN PERINATOLOGY

Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia

(2008) R. Akolekar et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY